Skip to content
Varieties from the European CatalogueGrown in FranceSlow dryingDispatched within 24 working hours — before noonEU delivery — 24-72 hRight of withdrawal — 14 daysCertificate available — per batch

Major phytocannabinoid

Unscheduled

CBGVCannabigerovarin

2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-propylbenzene-1,3-diol

Aliases.cannabigérovarine · cannabigerovarin · CBGV · cannabigérivarine

The propyl homologue of CBG, non-psychotropic.

Updated on

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

Identifiers

Formula
C₁₉H₂₈O₂
Molar mass
288.40 g·mol⁻¹
CAS
55824-11-8
PubChem CID
59444407
First described
Isolé du chanvre (Cannabis sativa L.) parmi les cannabinoïdes mineurs de type varine.
Origin
Hemp (Cannabis sativa L.), chiefly in varin-rich chemotypes.
InChIKey
YJYIDZLGVYOPGU-XNTDXEJSSA-N

In plain terms

A minor cannabinoid, a short-chain "cousin" of CBG, with no intoxicating effect.

Receptors and activity

  • CB1
    Partial agonist
  • CB2
    Partial agonist
  • TRPM8
    Antagonist
  • Agonist
  • Partial agonist
  • Antagonist
  • Modulator
  • Inverse agonist

Hover over a row for the precise value (Ki, EC50…)

Subjective signature

Hover over an axis to read its definition.

  • Calm
    55
  • Clarity
    65
  • Sleep
    25
  • Appetite
    45
  • High
    40

Editorial estimate, not clinical.

Pharmacology

CBGV is the propyl homologue of CBG: its side chain has only three carbons instead of five. Non-psychotropic, it arises from the decarboxylation of cannabigerovarinic acid (CBGVA) and feeds the plant's "varin" branch, which leads to THCV and CBDV. Like CBG, it shows modest affinity for the CB1 and CB2 receptors and interacts with the TRP channels; its data remain essentially preclinical.

Biosynthetic pathway

Arises from the decarboxylation of cannabigerovarinic acid (CBGVA), the "varin" branch (propyl chain) of cannabinoid biosynthesis. Formed in the glandular trichomes, it serves as the precursor of the propyl forms such as THCV and CBDV.

Structural classification

Class
Major phytocannabinoid
Origin
Hemp (Cannabis sativa L.), chiefly in varin-rich chemotypes.
Status
Unscheduled

Cannabinoïde de type résorcinol (branche varine), homologue propylique du cannabigérol.

References

  1. 1.PubChem CID 59444407 : Cannabigerovarin (identité, formule, InChIKey, IUPAC)
  2. 2.PubChem : synonymes et identifiants (CID 59444407)
  3. 3.MedChemExpress : Cannabigerovarin (CBGV), fiche réactif

Structured data

InChIKey
YJYIDZLGVYOPGU-XNTDXEJSSA-N
SMILES
CCCC1=CC(=C(C(=C1)O)C/C=C(\C)/CCC=C(C)C)O
Formula
C19H28O2
Molar mass
288.40 g·mol⁻¹
CAS
55824-11-8
PubChem CID
59444407
Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.